Capital Advisors Ltd’s Shattuck Labs STTK Stock Holding History

Capital Advisors Ltd’s Portfolio STTK Stock Details STTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-34	Closed	–	–	1505
2022 Q2	$0	Buy	+34	New	+$123	﹤0.01%	1310

Other funds holding STTK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

CEI

Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital Advisors Ltd's STTK Position: Q3 2022 in Review

Capital Advisors Ltd sold out of Shattuck Labs (STTK) in Q3 2022, closing a stake of 34 shares.

Capital Advisors Ltd first reported a position in STTK in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 63 funds tracked by Wall St. Rank hold STTK as of Q3 2022.

Capital Advisors Ltd reported no remaining Shattuck Labs position as of Q3 2022 after selling out during the quarter.
Capital Advisors Ltd sold 34 Shattuck Labs shares in Q3 2022.
Capital Advisors Ltd first reported a position in Shattuck Labs in Q2 2022 and held it in 1 quarter.
Capital Advisors Ltd's Shattuck Labs position peaked at $0 in Q2 2022.
63 funds tracked by Wall St. Rank held Shattuck Labs as of Q3 2022.

Based on Capital Advisors Ltd's 13F filing for Q3 2022, filed 9 Nov 2022.